Cargando…

Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes

Detalles Bibliográficos
Autores principales: Majewski, Colleen, Bakris, George L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876696/
https://www.ncbi.nlm.nih.gov/pubmed/25715414
http://dx.doi.org/10.2337/dc14-1596
_version_ 1782433278582587392
author Majewski, Colleen
Bakris, George L.
author_facet Majewski, Colleen
Bakris, George L.
author_sort Majewski, Colleen
collection PubMed
description
format Online
Article
Text
id pubmed-4876696
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-48766962016-06-10 Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Majewski, Colleen Bakris, George L. Diabetes Care Evolving Tactics With Inhibition of Sodium–Glucose Cotransporters American Diabetes Association 2015-03 2015-02-12 /pmc/articles/PMC4876696/ /pubmed/25715414 http://dx.doi.org/10.2337/dc14-1596 Text en © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
spellingShingle Evolving Tactics With Inhibition of Sodium–Glucose Cotransporters
Majewski, Colleen
Bakris, George L.
Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
title Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
title_full Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
title_fullStr Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
title_full_unstemmed Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
title_short Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
title_sort blood pressure reduction: an added benefit of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes
topic Evolving Tactics With Inhibition of Sodium–Glucose Cotransporters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876696/
https://www.ncbi.nlm.nih.gov/pubmed/25715414
http://dx.doi.org/10.2337/dc14-1596
work_keys_str_mv AT majewskicolleen bloodpressurereductionanaddedbenefitofsodiumglucosecotransporter2inhibitorsinpatientswithtype2diabetes
AT bakrisgeorgel bloodpressurereductionanaddedbenefitofsodiumglucosecotransporter2inhibitorsinpatientswithtype2diabetes